Narrative review / 2014
A review notes limited human data on methods to enhance resveratrol bioavailability despite laboratory promise.
This review evaluates strategies to overcome the poor bioavailability of resveratrol in humans to translate preclinical findings into clinical utility. Theoretical solutions include co-consumption with foods, micronized powders, combination with other phytochemicals, controlled-release devices, and nanotechnological formulations. Although laboratory models suggest these approaches improve bioavailability, very little data exist regarding resveratrol bioavailability in humans.
- Study type
- Narrative review
- Who was studied
- Humans (review of human data and clinical trials)
- What was measured
- Bioavailability and delivery of resveratrol
THE PAPER
Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution?
Smoliga JM, Blanchard O. Molecules, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.